7,858 results match your criteria: "Collaborative innovation Center for cancer Medicine[Affiliation]"

Temporal dynamics of immune cell patterns in bladder cancer patients receiving Bacillus Calmette-Guérin therapy.

Br J Cancer

December 2024

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China.

Background: Bacillus Calmette-Guérin (BCG) is capable of enhancing the infiltration of immune cells into the tumour. However the temporal dynamics of immune cell patterns in patients receiving BCG instillation remains unclear.

Methods: Ninety-six patients who underwent intravesical BCG therapy, comprising 46 responders and 50 non-responders, were retrospectively enroled to explore the evolving immune landscape.

View Article and Find Full Text PDF

Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics.

Nucleic Acids Res

January 2025

School of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.

High-quality schematic illustrations are fundamental to the publication of scientific achievements in biomedical research, which are crucial for effectively conveying complex biomedical concepts. However, creating such illustrations remains challenging for many researchers due to the need to devote a significant amount of time and effort to accomplish it. To address this need, we present the Generic Diagramming Platform (GDP, https://BioGDP.

View Article and Find Full Text PDF

The purpose of this study is to investigate the influence of different magnetic resonance (MR) sequences on the accuracy of generating computed tomography (sCT) images for nasopharyngeal carcinoma based on CycleGAN. In this study, 143 patients' head and neck MR sequence (T1, T2, T1C, and T1DIXONC) and CT imaging data were acquired. The generator and discriminator of CycleGAN are improved to achieve the purpose of balance confrontation, and a cyclic consistent structure control domain is proposed in terms of loss function.

View Article and Find Full Text PDF

RPS 2.0: an updated database of RNAs involved in liquid-liquid phase separation.

Nucleic Acids Res

January 2025

School of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.

Liquid-liquid phase separation (LLPS) is a crucial process for the formation of biomolecular condensates such as coacervate droplets, P-bodies and stress granules, which play critical roles in many physiological and pathological processes. Increasing studies have shown that not only proteins but also RNAs play a critical role in LLPS. To host LLPS-associated RNAs, we previously developed a database named 'RPS' in 2021.

View Article and Find Full Text PDF
Article Synopsis
  • A phase 3 trial compared the effectiveness and safety of zuberitamab combined with CHOP chemotherapy (Hi-CHOP) against rituximab combined with CHOP (R-CHOP) in patients with untreated CD20-positive diffuse large B-cell lymphoma (DLBCL).
  • The trial involved 487 patients, with a primary focus on the objective response rate (ORR) after six treatment cycles, finding that Hi-CHOP achieved a similar ORR to R-CHOP while demonstrating a significantly higher complete response (CR) rate in some analyses.
  • Long-term follow-up indicated that Hi-CHOP patients experienced improved duration of response (DOR), progression-free survival (PFS), and overall survival
View Article and Find Full Text PDF

The use of nanozymes has become a promising auxiliary approach to "turn on" surface-enhanced Raman scattering (SERS) signals for the label-free detection of disease markers. Nevertheless, there are still major challenges to develop bifunctional nanomaterials with both excellent enzyme-like activity and high SERS performance. To this end, a novel Z-scheme MoO/CuS heterojunction was first constructed as a powerful "two-in-one" substrate, which can not only catalyze leucomalachite green (LMG) to SERS-active malachite green (MG) but also serve as an efficient substrate to amplify the SERS signal of catalysate.

View Article and Find Full Text PDF

Factors Associated with IgG/IgM Levels after SARS-CoV-2 Vaccination in Patients with Head and Neck Cancer.

Trop Med Infect Dis

October 2024

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510060, China.

This study evaluated the factors influencing IgG/IgM antibody levels in 120 patients with head and neck cancer (HNC) following vaccination with inactivated SARS-CoV-2 vaccines. Each patient's demographic and clinical data were documented, and serum IgG and IgM antibodies were detected using a commercial magnetic chemiluminescence enzyme immunoassay kit. The results indicated that while all patients had received at least one vaccine dose, 95 tested positive for IgG and 25 were negative.

View Article and Find Full Text PDF

The Effect of a Prior Malignancy on the Prognosis of Patients With Extranodal NK/T-Cell Lymphoma.

Am J Ther

October 2024

Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Henan Hematology Institute, Zhengzhou, China.

View Article and Find Full Text PDF

Integrin-α6 is an attractive diagnostic and therapeutic biomarker in cancer, because it is highly expressed in several types of malignancies. Based on our previous findings, we designed a cyclic peptide, NOTA-A6P, to enhancing affinity, tumor uptake and serum stability, and then developed a cyclic radiotracer, [F]AlF-NOTA-A6P, for the specific detection of early colorectal cancer by PET/CT imaging. [F] AlF-NOTA-A6P was automatically labeled for colorectal cancer imaging in a novel synthesis module.

View Article and Find Full Text PDF

Targeting catalase in cancer.

Redox Biol

November 2024

Química y Farmacia, Facultad de Ciencias de La Salud, Universidad Arturo Prat, 1100000, Iquique, Chile; Instituto de Química Medicinal, Universidad Arturo Prat, 1100000, Iquique, Chile; Research Group in Metabolism and Nutrition, Louvain Drug Research Institute, Université Catholique de Louvain, 1200, Brussels, Belgium. Electronic address:

Healthy cells have developed a sophisticated network of antioxidant molecules to prevent the toxic accumulation of reactive oxygen species (ROS) generated by diverse environmental stresses. On the opposite, cancer cells often exhibit high levels of ROS and an altered levels of antioxidant molecules compared to normal cells. Among them, the antioxidant enzyme catalase plays an essential role in cell defense against oxidative stress through the dismutation of hydrogen peroxide into water and molecular oxygen, and its expression is often decreased in cancer cells.

View Article and Find Full Text PDF

Longitudinal assessment of quality of life indicators and prognosis in esophageal cancer patients with curative resection.

J Thorac Dis

September 2024

Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China.

Background: The relationship between quality of life and survival outcomes in esophageal cancer patients following curative resection is not well established. This study aimed to longitudinally assess quality of life indicators and their association with overall survival (OS) in these patients.

Methods: A total of 232 patients were included in the study, and their quality of life was prospectively assessed at different time points using the European Organisation for Research and Treatment of Cancer (EORTC) 30-item core quality of life questionnaire (QLQ-C30) and the disease-specific esophageal module (QLQ-OES18).

View Article and Find Full Text PDF

Development and validation of a hierarchical approach for lymphoma classification using immunohistochemical markers.

Cancer Med

October 2024

Collaborative Innovation Center for Cancer Medicine, State Key Laboratory of Oncology in South China, Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China.

Background: Accurate lymphoma classification is critical for effective treatment and immunohistochemistry is a cost-effective and time-saving approach. Although several machine learning algorithms showed effective results, they focused on a specific task of classification but not the whole classification workflow, thus impractical to be applied in clinical settings. Thus, we aim to develop an effective and economic machine learning-assisted system that can streamline the lymphoma differential diagnostic workflow using EBER in situ hybridization and immunohistochemical markers.

View Article and Find Full Text PDF

PYGB targeted by androgen receptor contributes to tumor progression and metabolic reprogramming in esophageal squamous carcinoma.

Cell Signal

December 2024

Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. Electronic address:

Background: The incidence and mortality rates of esophageal squamous cell carcinoma (ESCC) are conspicuously augmented in men in contrast to women. The androgen receptor (AR), prevalently associated with the manifestation of male characteristics, is regarded as a pivotal determinant in tumor progression. Nevertheless, its exact role in ESCC remains insufficiently delineated.

View Article and Find Full Text PDF

Multiple cell-death patterns predict the prognosis and drug sensitivity of melanoma patients.

Front Pharmacol

October 2024

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Article Synopsis
  • - The study focuses on melanoma treatment challenges, highlighting the need for a model that can predict prognosis and assess drug sensitivity using programmed cell death (PCD) modes.
  • - Researchers analyzed 13 PCD modes to create a Cell Death Index (CDI) based on gene signatures, which was validated with various data sources and showed distinct differences in patient outcomes.
  • - The CDI model effectively predicts melanoma prognosis and drug resistance, indicating that patients with higher CDI values have poorer postoperative outcomes.
View Article and Find Full Text PDF

RMVar 2.0: an updated database of functional variants in RNA modifications.

Nucleic Acids Res

January 2025

School of Life Sciences, State Key Laboratory of Oncology in South China, Cancer Center, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou 510060, China.

Evaluating the impact of genetic variants on RNA modifications (RMs) is crucial for identifying disease-associated variants and understanding the pathogenic mechanisms underlying human diseases. Previously, we developed a database called RMVar to catalog variants linked to RNA modifications in humans and mice. Here, we present an updated version RMVar 2.

View Article and Find Full Text PDF

QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion.

Proc Natl Acad Sci U S A

October 2024

Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, People's Republic of China.

Article Synopsis
  • - Dormant cancer stem cells (DCSCs) play a crucial role in tumor recurrence and metastasis due to their resistance to chemotherapy and ability to evade the immune system, mainly through enhanced PD-L1 signaling and the influence of quiescin sulfhydryl oxidase 1 (QSOX1).
  • - QSOX1, produced by quiescent fibroblasts, boosts PD-L1 expression in DCSCs and creates an environment that excludes CD8 T cells, thus supporting immune evasion.
  • - Targeting QSOX1 with Ebselen, in combination with anti-PD-1 and chemotherapy, shows promise for successfully eradicating dormant DCSCs and improving patient responses to treatment. *
View Article and Find Full Text PDF

Three vs 6 Cycles of Chemotherapy for High-Risk Retinoblastoma: A Randomized Clinical Trial.

JAMA

November 2024

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China.

Article Synopsis
  • Adjuvant therapy, specifically CEV chemotherapy, is crucial for treating high-risk unilateral retinoblastoma, but there hasn't been sufficient comparison between administering 3 vs. 6 cycles of this treatment.
  • A randomized trial involving 187 patients aimed to determine if 3 cycles of CEV chemotherapy is as effective as 6 cycles in terms of disease-free survival after enucleation.
  • The results showed that the 3-cycle regimen had comparable disease-free survival rates and was associated with fewer adverse events and lower costs, suggesting it could be a more efficient treatment option.
View Article and Find Full Text PDF

Purpose: The response of patients with biliary tract carcinoma (BTC) to immunotherapy varies widely, and there is an urgent need for biological indicators. The predictive value of inflammation based score (IBS) for the efficacy of immunotherapy in patients with BTC remains unclear, as the evidence is inconsistent. This study aimed to comprehensively examine the predictive value of IBS in peripheral blood on the survival of BTC patients receiving immunotherapy.

View Article and Find Full Text PDF

Unveiling the role of in Chinese colorectal cancer patients: a positive influence on tumor mutational burden.

Transl Cancer Res

September 2024

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.

Article Synopsis
  • * Researchers sequenced data from 94 CRC patients and found high mutation rates in several key oncogenes, specifically noting the G12D subtype had a higher mutation rate than others.
  • * The findings suggest that TMB influenced by co-mutations may serve as a valuable biomarker for predicting the effectiveness of immunotherapy treatments in CRC patients, particularly with the presence of specific co-mutations.
View Article and Find Full Text PDF

Recursive partitioning analysis model for de novo metastatic nasopharyngeal carcinoma treated with locoregional radiotherapy following chemoimmunotherapy.

ESMO Open

November 2024

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong Province, People's Republic of China; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Provincial Clinical Research Center for Cancer, Guangzhou, Guangdong Province, People's Republic of China; Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou, Guangdong Province, People's Republic of China. Electronic address:

Article Synopsis
  • - Chemoimmunotherapy combined with locoregional radiotherapy (LRRT) is the first-line treatment for de novo metastatic nasopharyngeal carcinoma (dmNPC), but patient outcomes can vary greatly due to the disease's heterogeneity.
  • - A study involving 364 patients developed a prognostic model using recursive partitioning analysis that categorized individuals into five risk groups based on factors like metastatic lesions and post-treatment Epstein-Barr virus DNA levels.
  • - The findings revealed that high-risk patients had significantly lower progression-free survival rates compared to medium and low-risk groups, with only medium-risk patients benefiting from local therapy for distant metastases.
View Article and Find Full Text PDF

Bladder cancer (BCa), as the most common malignant tumor of the urinary system, has received significant attention in research on the clinical application of artificial intelligence algorithms. Nevertheless, it has been observed that certain investigations use data from various medical facilities to train models for BCa, which may pose a privacy risk. Given this concern, protecting patient privacy during machine learning algorithm training is a crucial aspect that requires substantial attention.

View Article and Find Full Text PDF

Characteristics and treatment of epistaxis in nasopharyngeal carcinoma.

Oral Oncol

December 2024

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, 651 Dongfeng East Road, Guangzhou 510060, PR China; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangzhou 510060, PR China; Nasopharyngeal Cancer Center, Fifth Affiliated Hospital of Sun Yat-sen University, 52 Meihua East Road, Zhuhai, Guangdong 519000, PR China. Electronic address:

Objectives: To analyze the risk factors and explore effective treatments for epistaxis in nasopharyngeal carcinoma (NPC) patients.

Methods: From March 2006 to February 2020, 351 epistaxis patients visited our center and 195 patients meeting the inclusion criteria were enrolled in the study. Characteristics and treatments, including step-up hemostatic treatment (including medication, anterior ± posterior nostril packing, or further surgical hemostasis) and the CTPI emergency hemostasis method (including common carotid artery compression, tracheotomy / intubation, packing of nasal and nasopharynx, and interventional treatment), were analyzed.

View Article and Find Full Text PDF

Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence.

J Neurooncol

December 2024

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, PR China.

Purpose: Leptomeningeal disease (LMD) is a severe complication of melanoma with a very poor prognosis. Despite improved treatment strategies and prolonged survival, the incidence of LMD has increased over the past decade. This real-world study aims to evaluate the efficacy and safety of intrathecal anti-PD-1 treatment in melanoma patients with LMD.

View Article and Find Full Text PDF